1
|
Jiang L, Hu Y, Zhang Y, Zhao Y, Gao L, Dong Y, Liang Y, Guo H, Wu S, Zhang Y, Chen J, Zeng Q. Abnormal metabolism in melanocytes participates in the activation of dendritic cell in halo nevus. Clin Immunol 2024; 265:110300. [PMID: 38950722 DOI: 10.1016/j.clim.2024.110300] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2023] [Revised: 06/16/2024] [Accepted: 06/24/2024] [Indexed: 07/03/2024]
Abstract
A comprehensive analysis of spatial transcriptomics was carried out to better understand the progress of halo nevus. We found that halo nevus was characterized by overactive immune responses, triggered by chemokines and dendritic cells (DCs), T cells, and macrophages. Consequently, we observed abnormal cell death, such as apoptosis and disulfidptosis in halo nevus, some were closely related to immunity. Interestingly, we identified aberrant metabolites such as uridine diphosphate glucose (UDP-G) within the halo nevus. UDP-G, accompanied by the infiltration of DCs and T cells, exhibited correlations with certain forms of cell death. Subsequent experiments confirmed that UDP-G was increased in vitiligo serum and could activate DCs. We also confirmed that oxidative response is an inducer of UDP-G. In summary, the immune response in halo nevus, including DC activation, was accompanied by abnormal cell death and metabolites. Especially, melanocyte-derived UDP-G may play a crucial role in DC activation.
Collapse
Affiliation(s)
- Ling Jiang
- Department of Dermatology, The Third Xiangya Hospital, Central South University, No.138 Tongzipo Road, Changsha, Hunan 410013, PR China
| | - Yibo Hu
- Clinical Research Center, The Second Xiangya Hospital, Central South University, No.139 Renmin Road, Changsha, Hunan 410011, PR China
| | - Yushan Zhang
- Department of Dermatology, The Third Xiangya Hospital, Central South University, No.138 Tongzipo Road, Changsha, Hunan 410013, PR China
| | - Yuanyuan Zhao
- Department of Dermatology, The Third Xiangya Hospital, Central South University, No.138 Tongzipo Road, Changsha, Hunan 410013, PR China
| | - Lijuan Gao
- Department of Dermatology, The Third Xiangya Hospital, Central South University, No.138 Tongzipo Road, Changsha, Hunan 410013, PR China
| | - Yumeng Dong
- Department of Dermatology, The Third Xiangya Hospital, Central South University, No.138 Tongzipo Road, Changsha, Hunan 410013, PR China
| | - Yixuan Liang
- Department of Dermatology, The Third Xiangya Hospital, Central South University, No.138 Tongzipo Road, Changsha, Hunan 410013, PR China
| | - Haoran Guo
- Department of Dermatology, The Third Xiangya Hospital, Central South University, No.138 Tongzipo Road, Changsha, Hunan 410013, PR China
| | - Songjiang Wu
- Department of Dermatology, The Third Xiangya Hospital, Central South University, No.138 Tongzipo Road, Changsha, Hunan 410013, PR China
| | - Yuanmin Zhang
- Department of Dermatology, The Third Xiangya Hospital, Central South University, No.138 Tongzipo Road, Changsha, Hunan 410013, PR China
| | - Jing Chen
- Department of Dermatology, The Third Xiangya Hospital, Central South University, No.138 Tongzipo Road, Changsha, Hunan 410013, PR China
| | - Qinghai Zeng
- Department of Dermatology, The Third Xiangya Hospital, Central South University, No.138 Tongzipo Road, Changsha, Hunan 410013, PR China.
| |
Collapse
|
2
|
Abraham MJ, Goncalves C, McCallum P, Gupta V, Preston SEJ, Huang F, Chou H, Gagnon N, Johnson NA, Miller WH, Mann KK, Del Rincon SV. Tunable PhenoCycler imaging of the murine pre-clinical tumour microenvironments. Cell Biosci 2024; 14:19. [PMID: 38311785 PMCID: PMC10840224 DOI: 10.1186/s13578-024-01199-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2023] [Accepted: 01/19/2024] [Indexed: 02/06/2024] Open
Abstract
BACKGROUND The tumour microenvironment (TME) consists of tumour-supportive immune cells, endothelial cells, and fibroblasts. PhenoCycler, a high-plex single cell spatial biology imaging platform, is used to characterize the complexity of the TME. Researchers worldwide harvest and bank tissues from mouse models which are employed to model a plethora of human disease. With the explosion of interest in spatial biology, these panoplies of archival tissues provide a valuable resource to answer new questions. Here, we describe our protocols for developing tunable PhenoCycler multiplexed imaging panels and describe our open-source data analysis pipeline. Using these protocols, we used PhenoCycler to spatially resolve the TME of 8 routinely employed pre-clinical models of lymphoma, breast cancer, and melanoma preserved as FFPE. RESULTS Our data reveal distinct TMEs in the different cancer models that were imaged and show that cell-cell contacts differ depending on the tumour type examined. For instance, we found that the immune infiltration in a murine model of melanoma is altered in cellular organization in melanomas that become resistant to αPD-1 therapy, with depletions in a number of cell-cell interactions. CONCLUSIONS This work presents a valuable resource study seamlessly adaptable to any field of research involving murine models. The methodology described allows researchers to address newly formed hypotheses using archival materials, bypassing the new to perform new mouse studies.
Collapse
Affiliation(s)
- Madelyn J Abraham
- Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada
- Division of Experimental Medicine, McGill University, Montreal, QC, Canada
| | | | - Paige McCallum
- Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada
- Division of Experimental Medicine, McGill University, Montreal, QC, Canada
| | - Vrinda Gupta
- Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada
- Division of Experimental Medicine, McGill University, Montreal, QC, Canada
- University of British Columbia, Vancouver, BC, Canada
| | - Samuel E J Preston
- Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada
- Division of Experimental Medicine, McGill University, Montreal, QC, Canada
| | - Fan Huang
- Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada
- Division of Experimental Medicine, McGill University, Montreal, QC, Canada
| | - Hsiang Chou
- Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada
- Clinical Research Unit, Jewish General Hospital, Montreal, QC, Canada
| | - Natascha Gagnon
- Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada
| | - Nathalie A Johnson
- Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada
- Division of Experimental Medicine, McGill University, Montreal, QC, Canada
- Clinical Research Unit, Jewish General Hospital, Montreal, QC, Canada
| | - Wilson H Miller
- Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada.
- Division of Experimental Medicine, McGill University, Montreal, QC, Canada.
- Clinical Research Unit, Jewish General Hospital, Montreal, QC, Canada.
| | - Koren K Mann
- Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada.
- Division of Experimental Medicine, McGill University, Montreal, QC, Canada.
- Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada.
| | - Sonia V Del Rincon
- Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada.
- Division of Experimental Medicine, McGill University, Montreal, QC, Canada.
| |
Collapse
|